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We have sought to identify transcriptional pathways
in adipogenesis using an integrated experimental
and computational approach. Here, we employ
high-throughput DNase hypersensitivity analysis to
find regions of altered chromatin structure surround-
ing key adipocyte genes. Regions that display differ-
entiation-dependent changes in hypersensitivity were
used to predict binding sites for proteins involved in
adipogenesis. A high-scoring example was a binding
motif for interferon regulatory factor (IRF) family
members. Expression of all nine mammalian IRF
mRNAs is regulated during adipogenesis, and sev-
eral bind to the identified motifs in a differentiation-
dependent manner. Furthermore, several IRF pro-
teins repress differentiation. This analysis suggests
an important role for IRF proteins in adipocyte biol-
ogy and demonstrates the utility of this approach in
identifying cis- and trans-acting factors not previ-
ously suspected to participate in adipogenesis.
INTRODUCTION
Adipogenesis involves a sequential and ordered cascade of
gene expression events coordinated by transcription factors
that simultaneously induce tissue-specific gene expression
and repress alternate cell fates (Rosen and MacDougald,
2006). In adipogenesis, attention has focused on the nuclear
receptor PPARg and several members of the C/EBP family of
bZIP proteins, including C/EBPa, b, and d. More recently, other
proadipogenic factors have been identified, including KLF and
EBF proteins (Oishi et al., 2005; Jimenez et al., 2007; Mori
et al., 2005). Transcriptional repressors of adipogenesis have
also been identified, such as GATA2, GATA3, and KLF2
(Tong et al., 2000; Wu et al., 2005). These pro- and antiadipo-
genic proteins, working in concert with a number of transcrip-
tional cofactors, integrate a wide array of cellular inputs to
determine whether a precursor cell will initiate and complete
the differentiation process (Rosen and MacDougald, 2006;
Farmer, 2006).
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define transcriptional pathways in development, brought about
by new experimental methods as well as computational ap-
proaches (Elnitski et al., 2006). Some of these techniques are
amenable to high-throughput analysis, such as the combina-
tion of chromatin immunoprecipitation (ChIP) with microarrays
(ChIP-chip), but require advance knowledge of which transcrip-
tion factors may be involved (Negre et al., 2006; Weinmann,
2004). Other methods, like promoter analysis and electropho-
retic mobility shift assays (EMSAs), are not easily adaptable to
high-throughput format. Several computational techniques
have been devised to assist in motif recognition (Ji and Wong,
2006), and although many of these algorithms have been suc-
cessful at identifying already known cis elements, there has
been less success in predicting novel pathways. An additional
problem with most purely computational approaches is lack of
specificity: typically, many more binding sites are predicted
than actually participate in bona fide gene expression events.
Mapping DNase hypersensitive sites (DHSs) can be used to
identify cis elements with important biological functions (Krebs
and Peterson, 2000). This method relies on the ability of small
amounts of DNase I to digest regions of open or accessible chro-
matin. These regions are often associated with protein binding
and include enhancers, promoters, silencers, insulators, and
locus control regions. Despite the ability of DNase hypersensitiv-
ity analysis to identify important cis-acting elements, only a few
hundred such sites have been identified over a quarter of a cen-
tury. Limitations of the technique include the need for iterative
Southern blotting, relatively large amounts of starting material,
and significant radiation use. A few groups have improved upon
the traditional approach to DNase hypersensitivity by adapting
it to high-throughput technologies like quantitative polymerase
chain reaction (qPCR), massively parallel signature sequencing,
and tiled microarrays (McArthur et al., 2001; Crawford et al.,
2004, 2006a, 2006b; Sabo et al., 2004, 2006; Bernat et al., 2006).
Here, we used a qPCR-based DNase hypersensitivity strategy
to look for regulatory elements involved in adipocyte differentia-
tion. This approach yielded sites that were used as input
sequences in a computational algorithm designed to identify
overrepresented motifs involved in tissue-specific gene expres-
sion. One top-scoring motif corresponded to a binding site for
interferon regulatory factors (IRFs). We show that IRFs are
expressed in fat, are developmentally regulated, and bind to
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Interferon Regulatory Factors Inhibit AdipogenesisFigure 1. DNase Hypersensitive Sites Can Be Identified Flanking Adipocyte-Selective Genes
(A) DNase hypersensitivity results for day 7 adipocytes. The x axis represents the difference in cycle threshold (DCT) between DNase-digested and undigested
samples. The y axis represents the percent of all primer sets that displayed any given DCT. The red line corresponds to random primers (negative control). The
blue line corresponds to primers that amplify known DNase hypersensitive sites (DHSs) in other cell types (positive control). The green line describes results using
primer pairs derived from the adipocyte-selective gene set. See text for details.
(B) Top motifs identified by the computational algorithm DME in differentiation-dependent DHSs, ranked by error rate. The information displayed includes
the sequence logo; the best matching TRANSFAC profile including the accession number, the name of the TRANSFAC profile, and the Kullback-Leibler (KL)
divergence score of the discovered motif and the TRANSFAC motif; and the error rate.the predicted cis elements. Furthermore, some IRFs repress the
entire adipogenic process. Taken together, these studies dem-
onstrate the utility of integrating experimental and computational
techniques to identify factors and pathways in cellular differenti-
ation and tissue-specific gene expression.
RESULTS
qPCR-Based DNase Hypersensitivity Analysis
of Adipocyte Genes
We chose to study 27 genes that possessed two key character-
istics: (1) expression limited to very few tissues, including brown
and/or white adipose tissue, and (2) expression induced during
adipogenesis (see Figure S1 available online). DHSs are enriched
in the proximal 50 kb upstream of the transcriptional start site
(TSS) and in the first intron (Crawford et al., 2006b), so we re-
stricted our search to these areas. Areas of high conservation
and at least 70 bp in length were chosen on the assumption
that important regulatory sites tend to be clustered together, giv-
ing them a size larger than the typical 6- to 10-mer bound by an
individual transcription factor (Elnitski et al., 2006). Overall, we
identified 268 such regions flanking our genes of interest (Table
S1); these regions were used to design PCR primers.
We next harvested nuclei from 3T3-L1 cells prior to differenti-
ation (day 0) and after conversion to mature adipocytes (day 7)
(Figure S2). Nuclei were exposed to variable concentrations of
DNase I, and samples were selected for further analysis based
on similarity of degree of digestion (Figure S2). In addition to
the 268 primer sets mapping to adipose-selective genes, we
also tested primer sets randomly distributed throughout the
mouse genome (negative control) and primer sets flanking
DHSs found in several other cell types (positive control).The critical parameter for each region is the difference in ampli-
fication cycle threshold (DCT) between samples treated with and
without DNase I. A high DCT means that DNase I mediated tem-
plate reduction and implies the existence of a DHSwithin the am-
plicon; a lowDCTsuggests theopposite.Data fromday7samples
are shown in Figure 1A. As expected, randomly selected regions
are generally not hypersensitive anddisplay a lowDCT,while sites
that are hypersensitive in nonadipose tissues also show a right-
ward shift in adipocytes. The adipocyte-selective set displays
an intermediate pattern. Comparing the DCT at day 0 (Figure S3)
to theDCT at day 7 allowedus to determinewhichDHSs showdif-
ferentiation dependence. There were 32 such regions, mapping
to 14 of the original 27 genes (51.9%; see Table S2).
Initial Characterization of Differentiation-Dependent
DHSs
One of the DHSswas Fabp4 I8 (identified by gene and ‘‘island’’ or
‘‘I’’ number). This region contains two well-validated PPARg
binding sites and is the key element required for adipose-specific
expression of FABP4 (Graves et al., 1992; Tontonoz et al., 1994).
The presence of this region among our differentiation-dependent
DHSsservedasanunintendedpositive control.Weestimated the
size of thisDHSat approximately 1 kbbydesigning primers flank-
ing both sides of the site at 700 bp intervals (Figure S4), in accor-
dancewith the size of DHSs reported elsewhere (Frenster, 1976).
Our next goal was to confirm that differentiation-dependent
DHSs display properties associated with transcriptional regula-
tion. We first looked at histone modification in some of these
regions using ChIP. Fifteen of 21 DHSs tested showed a differen-
tiation-dependent accumulation of acetyl groups on histone 3
(H3), a modification associated with transcription factor binding
sites (Figure S5) (Villar-Garea and Imhof, 2006). We also tested
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Tissue In Vivo and In Vitro
(A) qPCR-based expression of IRF1–9 in tissues
from male FVB mice. Br, brain; H, heart; Lu, lung;
Liv, liver; K, kidney; Sp, spleen; Int, intestine;
WAT, white adipose tissue; BAT, brown adipose
tissue. Data are expressed as mean ± SEM fold
induction relative to IRF mRNA expression in
WAT; all values are normalized to 36B4 expres-
sion. n = 3.
(B) IRF expression was assessed in samples of
fractionated fat pads from C57BL/6 mice. SVF,
stromal-vascular fraction; Macs, F4/80+ macro-
phages; Ads, adipocytes. Data are expressed as
mean ± SD fold induction relative to IRF mRNA
expression in SVF. n = 6, **p < 0.01 versus SVF;
n.d., not detectable.
(C) IRF expression during 3T3-L1 differentiation.
Note that the time scale is not linear; the shaded
area indicates time points <24 hr. Data are normal-
ized to 36B4 expression and are expressed as fold
induction relative to IRF mRNA at day 0.the ability of DHSs to bind factors from adipocyte nuclear
extracts. All four sites tested bound to factors from 3T3-L1 adi-
pocytes, and three of the four formed complexesmore efficiently
with day 7 extracts than with extracts from day 0 preadipocytes
(Figure S7 and data not shown).
Computational Analysis of Hypersensitive Sites
Identifies Relevant cis Motifs
In order to identify factors that bind to DHSs, we used a compu-
tational algorithm called Discriminating Matrix Enumerator
(DME) that has shown promise in identifying tissue-specific tran-
scriptional pathways (Smith et al., 2005). DME chooses motifs
that best distinguish between two sequence sets; in this case,
we compared DHSs to randomly selected sequences from the
regions surrounding the DHSs. The top ten DME-discovered
motifs and their best matching TRANSFAC profiles are shown
in Figure 1B. Interestingly, two of the top-scoring hits weremotifs
for HMGI-Y, a protein already known to participate in adipogen-
esis (Melillo et al., 2001). Similarly, a PPAR motif also scored
highly, as did a NF-kB motif. These factors are well known to
activate and inhibit adipocyte gene expression, respectively
(Tontonoz et al., 1994; Ruan et al., 2003). Among the top-scoring
motifs was a binding site for IRFs. The Search Tool for Occur-
rences of Regulatory Motifs (STORM) (Schones et al., 2007)
was used to predict putative IRF response elements (IRF-REs)
corresponding to this IRF profile (Table S3).
IRFs Are Expressed in Adipose Tissue and Regulated
during Differentiation
Mammals possess nine distinct IRF genes, which play key roles
in several aspects of the immune response (Taniguchi et al.,
2001; Lohoff and Mak, 2005). There have been no reports, how-
88 Cell Metabolism 7, 86–94, January 2008 ª2008 Elsevier Inc.ever, of IRF expression or function in adipocytes. Using qPCR,
we ascertained that all IRF isoforms are expressed in murine
adipose tissue (Figure 2A). IRF4 was particularly interesting in
that it showed relative tissue specificity for adipose tissue and
spleen. These data were confirmed using northern blotting for
all IRFs (Figure S6A) and western blotting for IRF4 (Figure S6B).
Adipose depots contain immune cells, raising the issue of
whether IRFs are expressed in adipocytes per se. White adipose
pads were fractionated into adipocytes, macrophages, and
stromal-vascular cells, and expression of IRF isoforms was
measured using qPCR (Figure 2B). All IRFs were expressed in
the adipocyte fraction, and all except IRF5 were more highly
expressed in adipocytes than in resident macrophages.
Interestingly, all nine IRFs show developmental regulation dur-
ing adipogenesis in cultured fat cells (Figure 2C), generally falling
into three distinct expression patterns. Most IRFs (IRF1, IRF2,
IRF6, IRF7, IRF8, and IRF9) are expressed in preadipocytes
and are then repressed early after the induction of differentiation
before becoming re-expressed in mature adipocytes. The
expression of IRF3 and IRF4 is induced during differentiation.
Finally, IRF5 is highly expressed in preadipocytes but disappears
as adipogenesis proceeds.
IRFs Bind to Predicted Motif Regions in DHSs In Vitro
and In Vivo
To determine whether IRF proteins bind to identified motifs
within DHSs, we usedChIP analysis in cells at day 0 or day 7 after
the induction of differentiation, focusing on IRF1, IRF2, IRF3,
IRF4, and IRF8 due to the availability of suitable antibodies.
Figure 3A shows that several IRFs bind to the predicted DHSs,
many in a developmentally regulated manner. For example,
Acdc I5 and Aoc3 I1 show significantly more IRF binding in
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(A) Binding of IRFs to DHSs in adipocytes using ChIP. Data are representative of three experiments.
(B) EMSA using Cd36 I3 as the probe. Left: extract from day 0 3T3-L1 preadipocytes was coincubated with radiolabeled Cd36 I3 probe and an IRF-specific an-
tibody or IgG. Right: a similar experiment using cells transfected with IRF-expressing plasmids. In (B) and (C), arrows denote complexes containing IRF isoforms,
while arrowheads denote an antibody-mediated supershift. Asterisks in (C) indicate a complex of uncertain provenance.
(C) EMSA using Slc2a4 I2 as the probe. Left: extract from day 0 cells was coincubated with labeled Slc2a4 I2 probe and an IRF-specific antibody or IgG. Right:
a similar experiment using cells transfected with IRF-expressing plasmids.
(D) The murine Slc2a4 promoter is shown with the IRF response element (IRF-RE) from 801 to 788 (top). Constructs with and without the IRF-RE were
cotransfected into day 5 3T3-L1 adipocytes with plasmids expressing IRF2, IRF4, or empty vector, and luciferase expression was determined 24 hr later. Results
are expressed as mean ± SD (n = 3). *p < 0.05 relative to vector control; yp < 0.05 relative to wild-type (Wt) promoter.day 7 adipocytes than in day 0 preadipocytes. Other DHSs, such
as Plin I4 and Pparg I9, show constitutive IRF binding in both
developmental states.
EMSAs were employed to further characterize the binding of
specific IRFs to the predicted motifs. For the Cd36 I3 motif, for
example, enhanced complex formation was seen using nuclear
extracts prepared from 3T3-L1 cells overexpressing IRF2,
IRF3, IRF4, and IRF8 (Figure 3B), all of which were also shownto bind this region in the ChIP assay. Using antibodies against
these factors, we were able to demonstrate supershifting of
complexes containing IRF2, IRF4, and IRF8 and diminution of
the complex containing IRF3. Supershifting of IRF2 is also visible
in the absence of ectopic overexpression. Similarly, when the
probe was switched to the putative IRF-RE from the Glut4
gene (Slc2a4 I2), we observed enhanced complex formation
with IRF2 and IRF4 and supershifting with anti-IRF2 (Figure 3C).
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IRFs, including Pparg I8, Pparg I9, and PlinI4 (data not shown).
For Pparg I8, we used a consensus IRF-RE to successfully com-
pete for binding to a factor in day 7 extract; a mutant consensus
motif was ineffective (Figure S7).
Finally, we generated a construct in which luciferase is driven
by the808 bp murine Slc2a4 promoter, containing the putative
IRF motif at the distal end. Cotransfected IRF4, but not IRF2,
repressed expression from this construct (Figure 3D). A small
deletion eliminating only the putative IRF motif prevented IRF4
from repressing luciferase expression. Taken together, the
ChIP, EMSA, and transactivation assay data indicate that these
putative motifs are bona fide IRF binding sites.
IRFs Are Endogenous Regulators of Adipogenesis
and Adipocyte Gene Expression
We next sought to determine whether IRFs play a functional role
in adipocyte differentiation. IRF isoforms were introduced by ret-
roviral transduction into 3T3-L1 preadipocytes, which were then
treated with dexamethasone, methylisobutylxanthine, and insu-
lin (DMI) (see Figure S8A and Table S6). IRF3 and IRF4 were the
only isoforms with a significant effect on lipid accumulation (Fig-
ure 4A) and terminal gene expression (Figure 4B). All other IRF
isoforms repressed at least one nonoverlapping target gene,
suggesting specificity in the IRF transcriptional response.
We also performed studies using lentiviral delivery of short
hairpin RNAs (shRNAs) directed against individual IRF isoforms
in 3T3-L1 preadipocytes (Figure S8B).Wewere unable to identify
a specific hairpin that reduced levels of IRF4 or IRF8 despite
extensive efforts; these two factors are thus excluded from this
analysis. Of the remaining IRFs, only IRF1 and IRF3 knockdown
provoked consistently elevated oil red O staining (Figure 4C).
Reduction of IRF1 and IRF3 during differentiation also resulted
in enhanced adipocyte gene expression (day 7 results are shown
in Figure 4D; see Figure S9 for full time-course data), including
PPARg and C/EBPa. Consistent with the overexpression exper-
iments, all other IRFs tested except IRF5 showed an effect on
one or more individual genes.
We also asked whether IRFs might affect adipocyte gene
expression outside of the context of differentiation. Transient
transfection of IRF expression constructs was performed in
3T3-L1 adipocytes 5 days after DMI treatment, with gene
expression assessed on day 7. We examined the expression
of eight adipocyte target genes, including those for which an
IRF-RE was predicted by the DNase hypersensitivity analysis.
All IRF isoforms repressed adipocyte-specific gene expression
(Figure S11A). However, most IRF family members are activators
of gene expression in immune cells. We thus measured levels of
known immune-related IRF target genes (e.g., Ifna, Ccl5, Cxcl9,
Gata3, and Il15) in the setting of IRF overexpression in adipo-
cytes. These genes were generally activated by IRF overexpres-
sion, and in no case was repression seen (Figure S11B). These
results indicate that IRFs do not generally reduce gene expres-
sion in adipocytes but rather repress adipocyte-specific gene
expression selectively.
Finally, we performed analogous loss-of-function experiments
by transfecting mature (i.e., day 5) adipocytes with shRNA
directed against specific IRF isoforms (Figure S10). In the case
of IRF4, the absence of an identifiable shRNA construct led us
90 Cell Metabolism 7, 86–94, January 2008 ª2008 Elsevier Inc.to employ a siRNA SMARTpool (Dharmacon) instead. As pre-
dicted, expression of most of the adipocyte-specific genes
was enhanced by IRF knockdown (Figure S11C). Some target
genes showed specificity for a limited number of IRFs; for exam-
ple, Plin and Pparg were enhanced only by reduction of IRF3,
andCd36 andSlc2a4were affected only by IRF3 and IRF4. Other
genes, such as Acdc and Fabp4, were affected by larger (but not
completely overlapping) sets of IRFs, again suggesting specific-
ity of IRF action in adipocytes.
DISCUSSION
This study reports the integrated use of DNase hypersensitivity
analysis, computational algorithms, and experimental biology
to predict and confirm transcriptional regulators. A particular
strength of this study is the use of cells pre- and postdifferentia-
tion, which allowed temporal changes in DHSs to be used to se-
lect for regulators with an impact on the developmental process.
The qPCR-based method of DNase hypersensitivity analysis
requires a priori selection of regions of interest, which necessar-
ily introduces some bias. An alternative strategy is to use over-
lapping sets of primers, which can achieve complete coverage
of a given region. This approach lacks practicality, however,
when applied to large stretches of sequence such as we used
here. It is expected that array-based detection or Solexa se-
quencing of DHSs will ultimately solve this problem (Crawford
et al., 2006a; Sabo et al., 2006). For the current study, we intro-
duced certain biases to make the project tractable. First, the
choice of genes was justified on the basis of their adipose selec-
tivity and their induction during adipogenesis. There are many
more genes expressed in adipocytes, and their inclusion would
increase the robustness of the analysis. Second, we limited the
regions of study to the proximal upstream 50 kb and the first
intron. These regions are enriched for DHSs, but relevant sites
can certainly exist in other locations as well, such as 30 flanking
sequence, other introns, and distal intergenic regions. Finally,
we imposed a somewhat arbitrary size and conservation cutoff
(70 bp and 70% identity across species). Approximately 60%
of DHSs are located in such highly conserved regions, but
many sites of interest are either species specific or display less
conservation than required here (Crawford et al., 2006b).
Despite these limitations, we were able to rapidly increase the
number of known adipose differentiation-dependent DHSs.
These sites accumulate acetylated histones over the course of
adipose conversion and bind to adipocyte nuclear proteins.
The size of one DHS was measured and found to be approxi-
mately 1 kb in length, consistent with the reported size of
many other such regions (Frenster, 1976). These characteristics
suggest that the DHSs we identified are bona fide transcription
factor binding sites.
Our goal was not simply to characterize new adipose-specific
DHSs, however, but to identify transcriptional pathways that reg-
ulate adipocyte gene expression.We therefore employed a com-
putational algorithm (DME) to identify overrepresented motifs in
the DHSs, several of which correlated with transcription factors
associated with adipogenesis, including HMGI-Y, PPARg, and
NF-kB. The presence of a putative IRF binding site among the
top-scoring motifs, however, was a surprise, as these well-stud-
ied proteins have not been described in fat.
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(A) 3T3-L1 preadipocytes were transduced with retroviruses expressing IRFs and differentiated with dexamethasone, methylisobutylxanthine, and insulin (DMI).
Cells were stained with oil red O 7 days post-DMI treatment.
(B) Cells shown in (A) were harvested at day 7 post-DMI treatment, and qPCRwas used to determine levels of adipocyte genes relative to control cells. All samples
are normalized to 36B4. Results are expressed as mean ± SD (n = 3). *p < 0.05, **p < 0.01 versus vector control.
(C) 3T3-L1 preadipocytes were transduced with lentiviruses expressing shRNAs directed against the indicated IRF isoforms. Oil red O staining was performed at
days 3, 5, and 7 post-DMI treatment.
(D) Cells shown in (C) were harvested at day 7 post-DMI treatment, and qPCR was used to determine levels of adipocyte genes relative to control cells. All
samples are normalized to 36B4. Results are expressed as mean ± SD (n = 3). *p < 0.05, **p < 0.01 versus vector control.All nine mammalian IRFs are expressed in murine adipocytes,
and all show developmental regulation during adipogenesis.
Some IRFs (e.g., IRF4) even display relative specificity for
adipose tissue. Importantly, we show that IRFs not only are
expressed in adipocytes but bind to the sequences predictedby DME and repress adipogenesis. This is particularly true of
IRF3 and IRF4, though all IRFs other than IRF5 appear to have
some effect when specific adipocyte genes are examined. This
suggests that different IRF isoforms have distinct yet overlap-
ping roles in adipogenesis and in regulating gene expression inCell Metabolism 7, 86–94, January 2008 ª2008 Elsevier Inc. 91
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entirely consistent with their inclusion in DHSs, which often con-
tain silencer elements (Dirks et al., 1993; Tanaka et al., 1998;
Hermann and Heckert, 2005). It is worth noting that the actions
of IRF3, IRF4, and some other members of this family are similar
to those of NF-kB, another transcription factor that activates
immunoregulatory genes and represses adipocyte-specific
gene expression.
IRFs have mainly been studied in the context of immune reg-
ulation, and there is growing appreciation of the importance of
inflammatory pathways in adipocytes, which are generally asso-
ciated with insulin resistance (Hotamisligil, 2006). For example,
inflammatory signals and fatty acids are both ligands for toll-
like receptor 4 (TLR4), which mediates reduced insulin action
in fat cells (Shi et al., 2006). In macrophages and other immune
cells, TLRs exert many of their effects through changes in IRF
activity, and we speculate that IRFs may mediate the effects of
TLR4 (or other TLRs) in adipocytes (Taniguchi et al., 2001; Lohoff
and Mak, 2005). Interestingly, IRF3 has been shown to repress
retinoid X receptor (RXR)- and liver X receptor (LXR)-mediated
signaling in hepatocytes and macrophages, respectively (Cast-
rillo et al., 2003; Chow et al., 2006). A similar effect in adipocytes
would be predicted to reduce gene expression associated with
lipid storage and other key adipose functions, consistent with
our findings of repression of adipocyte genes. IRFs mediate their
actions in immune cells through a complex series of protein-pro-
tein interactions and posttranslational modifications (Taniguchi
et al., 2001; Lohoff and Mak, 2005). We are currently investigat-
ing these issues in adipocytes, in addition to determining the
metabolic consequences of IRF action in vivo.
In summary, these studies demonstrate the power of an inte-
grated computational and experimental approach to identify
transcriptional regulators. DNase hypersensitivity analysis in par-
ticular can be a useful method to study the simultaneous regula-
tion of multiple genes involved in development and physiology.
EXPERIMENTAL PROCEDURES
Cell Culture
3T3-L1 cells were cultured in DMEM with 10% BCS in 5% CO2. Two days
postconfluence, cells were exposed to DMEM/10% FBS with dexamethasone
(1 mM), insulin (5 mg/ml), and isobutylmethylxanthine (0.5 mM). After 2 days,
cells were maintained in medium containing insulin and FBS until ready for
harvest at day 7.
Generation of Retroviral Constructs
The coding regions of mouse IRFs were isolated from 3T3-L1 adipocytemRNA
by RT-PCR using TaKaRa Ex Taq polymerase (Takara Bio Inc.) and subcloned
into pMSCV (Clontech). To generate IRF-pMSCV expression vectors, IRF1,
IRF4, IRF8, and IRF9 cDNAs were cloned into the BglII and EcoRI sites
of the pMSCV vector. IRF3, IRF6, and IRF7 cDNAs were cloned into the
XhoI and EcoRI sites of the pMSCV vector. IRF2 cDNA was cloned into the
XhoI and HpaI sites of the pMSCV vector. IRF5 cDNA was cloned into
the HpaI and EcoRI sites of the pMSCV vector.
Transfection
Five days after adipogenic stimulation, 3T3-L1 cells were detached with tryp-
sin and transfected with 4 mg of IRF-pMSCV or empty pMSCV along with 0.1
mg of EGFP expression vector using the Amaxa nucleofection system (Amaxa
Biosystems). Cells were then cultivated in DMEM/10% FBS. Forty-eight hours
posttransfection, RNA was harvested and subjected to qPCR. For experi-
ments with shRNA, day 5 3T3-L1 adipocytes were transfected with shRNA
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duplexes (Dharmacon) or nontargeting control siRNA was transfected. RNA
was harvested 48 hr later and subjected to qPCR.
Animals
FVB mice were obtained from Charles River Laboratories and fed a standard
diet (8664, Harlan Teklad). Mice were maintained under a 14 hr light/10 hr
dark cycle at constant temperature (22C) with free access to food and water.
For analysis of IRF mRNA expression in various tissues, 10-week-old male
FVB mice were used. All animal studies were approved by the Institutional
Animal Care and Use Committee of Beth Israel Deaconess Medical Center.
Chromatin Immunoprecipitation
3T3-L1 cells were treated with 1% formaldehyde for 10–15 min at room tem-
perature to crosslink DNA-protein complexes. Genomic DNA was sheared
using a Sonic Dismembrator Model 100 (Fisher Scientific) to obtain fragments
ranging from 200 bp to 1 kb. ChIP was performed using a kit fromUpstate, with
3 mg of primary antibody or rabbit IgG. The following primary antibodies were
used: rabbit anti-IRF1 (sc-640), rabbit anti-IRF2 (sc-498), rabbit anti-IRF3 (sc-
9082), rabbit anti-IRF4 (sc-6059), and rabbit anti-ICSBP (sc-6058) (Santa Cruz
Biotechnology); rabbit anti-Histone H3 (ab1791-100) (Abcam); and rabbit anti-
acetyl-histone H3 (06-599) (Upstate). Crosslinking was reversed and purified
DNA was subjected to PCR amplification using TaKaRa Ex Taq polymerase.
The PCR products were analyzed by electrophoresis on a 3% agarose gel.
The primers used for the ChIP assay were the same as those used to amplify
the conserved islands (Table S4).
Electrophoretic Mobility Shift Assay
Nuclear extracts were prepared from 3T3-L1 cells during differentiation as
described previously (Graves et al., 1992). Oligonucleotide probes (Sigma-
Genosys) were labeled with [g-32P]ATP by T4 polynucleotide kinase (Invitro-
gen). Binding reactions containing 10 mg of the nuclear extract, 32P-labeled
probe (20,000 cpm), and 1 mg of poly(dI:dC) (Sigma) in binding buffer (20
mM HEPES [pH 7.6], 1 mM EDTA, 1 mM dithiothreitol, and 100 mM KCl)
were performed at 25C for 30 min. Samples were run on 4% nondenaturing
acrylamide gels in 13 Tris-glycine-EDTA buffer (pH 7.9). Sequences of
EMSA probes used were as follows: IRF-RE, 50-CTCACGCTTTGGAAAGTG
AAACCTACCTCACTC-30; IRF-RE (mut), 50-CTCACGCTTTGGACAGTGACA
CCTACCTCACTC-30; PpargI8 putative IRF-RE, 50-CTTCCCACTTCTCATTTC
AATGTGTA-30; Cd36 I3 probe, 50-AGGAAAGGAAAGGAAAGGAAAGGAAA
G-30; Slc2a4 I2 probe, 50-TGATCGTCCTTTCTTTCCACGCATCT-30. For super-
shifting studies, extracts were incubated with 10 mg of specific IRF antibody or
rabbit IgG (using the same antibodies described above for ChIP assays) on ice
for 1 hr before adding labeled probes.
Analysis of Gene Expression by qPCR
Total RNA was extracted from cells using TRIzol reagent (Invitrogen) following
the manufacturer’s instructions. Fat pads were fractionated into adipocytes,
macrophages, and stromal-vascular cells as described in Jimenez et al.
(2007). First-strand cDNA synthesis was performed using RETROscript (Am-
bion). Total RNA was converted into first-strand cDNA using oligo(dT) primers
as described by the manufacturer. PCR was performed using cDNA synthe-
sized from 1.5 mg total RNA in an Mx3000P qPCR system (Stratagene) with
specific primers and SYBR Green PCR Master Mix (Stratagene). The relative
abundance of mRNAs was standardized using 36B4 mRNA as the invariant
control. Primers used are listed in Table S3.
Luciferase Reporter Assay
The indicated regions of the murine Slc2a4 (Glut4) promoter were PCR ampli-
fied and ligated into pGL3-Basic (Promega). Day 5 3T3-L1 adipocytes were
transfected using electroporation as described above. Transfections were
performed using 2 mg of reporter construct along with 2 mg of IRF-pMSCV
expression vector (or pMSCV alone), along with 0.2 mg of galactosidase
expression vector. Luciferase activity was measured 24 hr after transfection
using the Galacto-Star luciferase reporter assay (Roche) according to the
manufacturer’s instructions.
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IRF-pMSCV constructs were transfected into Phoenix packaging cells using
the CellPhect transfection kit (Amersham Biosciences). 3T3-L1 preadipocytes
were transduced with viral supernatants and then selected in puromycin.
Lentiviral Constructs and Lentiviral Infection
IRF shRNA constructs in pLKO.1 designed by The RNAi Consortium at the
Broad Institute were obtained from Sigma. Each shIRF construct was trans-
fected into 293T packaging cells using the CellPhect transfection kit along
with a pCMV-dR8.91- and a VSV-G-expressing plasmid. 3T3-L1 cells were
transduced with viral supernatants, and cells were selected in puromycin.
The constructs chosen for the knockdown experiments were: IRF1, TRC
N0000077441; IRF2, TRCN0000071473; IRF3, TRCN0000085242; IRF5,
TRCN0000081565; IRF6, TRCN0000085330; IRF7, TRCN0000077290; IRF9,
TRCN0000081654.
Statistical Analysis
Unpaired two-tailed Student’s t test or one-way ANOVAwas used for compar-
ison. p < 0.05 was considered statistically significant.
Additional methods can be found in the Supplemental Experimental Proce-
dures.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, eleven figures, and six tables and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/7/1/86/DC1/.
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